HTR3A: 5-hydroxytryptamine receptor 3A
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation- selective channel complexes, which when activated cause fast, depolarizing responses in neurons. {ECO:0000269|PubMed:10521471, ECO:0000269|PubMed:12867984, ECO:0000269|PubMed:17392525, ECO:0000269|PubMed:9950429}.
- Drugs that act on it: 7
- With a US drug page: 5
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Alosetron | Approved | Serotonin 3a (5-HT3a) receptor antagonist | Antagonist | Boxed warning |
| Dolasetron | Approved | Serotonin 3a (5-HT3a) receptor antagonist | Antagonist | — |
| Metoclopramide | Approved | Serotonin 3a (5-HT3a) receptor antagonist | Antagonist | Boxed warning |
| Palonosetron | Approved | Serotonin 3a (5-HT3a) receptor antagonist | Antagonist | — |
| Vortioxetine | Approved | Serotonin 3a (5-HT3a) receptor antagonist | Antagonist | Boxed warning |
| Granisetron | — | Serotonin 3a (5-HT3a) receptor antagonist | Antagonist | — |
| Ondansetron | — | Serotonin 3a (5-HT3a) receptor antagonist | Antagonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Chemotherapy-induced nausea and vomiting
- 0.61
- Post operative nausea and vomiting
- 0.60
- Nausea
- 0.60
- Schizophrenia
- 0.60
- Cancer
- 0.60
- Vomiting
- 0.59
- Gastrointestinal disease
- 0.53
- Gastroparesis
- 0.48
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- HTR3A
Drugs and mechanisms are from ChEMBL CHEMBL1899 (CC BY-SA 3.0). Gene name, function (UniProt P46098, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets